Clinical Trials for Blueprint Medicines

Explore 11 clinical trials worldwide

Showing 1-11 of 11 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Blueprint Medicines

Clinical Trials (11)

NCT07143669
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
N/ANot yet recruiting
450 participants
Started: Sep 30, 2025 · Completed: Oct 31, 2028
3 conditions1 sponsor0 locations
NCT06931405
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
PHASE2Recruiting
105 participants
Started: May 28, 2025 · Completed: Dec 31, 2026
2 conditions1 sponsor32 locations
NCT06922448
Study of BLU-808 in Allergic Rhinoconjunctivitis
PHASE2Recruiting
54 participants
Started: Apr 14, 2025 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06748001
Avapritinib Rollover Study
PHASE4Recruiting
60 participants
Started: Nov 28, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor5 locations
NCT06327685
Avapritinib With Decitabine in Patients With SM-AHN
PHASE1Recruiting
34 participants
Started: Mar 13, 2024 · Completed: Mar 31, 2027
1 condition2 sponsors7 locations
NCT05252416
(VELA) Study of BLU-222 in Advanced Solid Tumors
PHASE1/PHASE2Active, not recruiting
366 participants
Started: Apr 7, 2022 · Completed: Sep 30, 2026
9 conditions1 sponsor23 locations
NCT04773782
A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
PHASE1/PHASE2Active, not recruiting
37 participants
Started: Feb 24, 2022 · Completed: Dec 30, 2025
3 conditions1 sponsor26 locations
NCT04910685
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
PHASE2/PHASE3Recruiting
534 participants
Started: Nov 30, 2021 · Completed: Sep 30, 2032
2 conditions1 sponsor53 locations
NCT04927260
French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients
N/AActive, not recruiting
25 participants
Started: Mar 31, 2021 · Completed: Dec 31, 2024
3 conditions2 sponsors7 locations
NCT05826756
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
N/ARecruiting
1,300 participants
Started: Aug 15, 2020 · Completed: Dec 31, 2025
2 conditions14 sponsors1 location
NCT03731260
(PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis
PHASE2Active, not recruiting
251 participants
Started: Apr 16, 2019 · Completed: Jun 23, 2027
1 condition1 sponsor49 locations